![]() |
¿¬°£Á¤º¸ ¼ºñ½º
»óǰÄÚµå
302689
½Å¾à R&D ÆÄÀÌÇÁ¶óÀÎ µ¥ÀÌÅͺ£À̽º : ¿¬°£ ±¸µ¶R&D Drug Pipeline Database: 1-Year Subscription |
º» ¿¬°£Á¤º¸ ¼ºñ½º¿¡¼´Â 17,000°Ç ÀÌ»óÀÇ ½Å¾à °³¹ß ÆÄÀÌÇÁ¶óÀÎ ÇÁ·ÎÁ§Æ® °ü·Ã °¢Á¾ µ¥ÀÌÅÍ¿¡ ´ëÇÑ ¿Â¶óÀÎ ¾×¼¼½º ±ÇÇÑÀ» Á¦°øÇϸç, °¢ ÇÁ·ÎÁ§Æ®ÀÇ Ç¥Àû¡¤ÈÇÕ¹° Ŭ·¡½º¡¤Á¦Ç° Ä«Å×°í¸®¡¤°³¹ß ±â¾÷¡¤Áö¿ª¡¤Ä¡·á ºÐ¾ß¡¤ÀûÀÀÁõ¡¤°³¹ß ´Ü°è µîÀÇ µ¥ÀÌÅ͸¦ ÀüÇØµå¸³´Ï´Ù.
Subscription to La Merie Publishing's proprietary ‘R&D Drug Pieline Database’ provides 24/7 online access to information about more than 25,500 project entries (files) for therapeutic drugs on the market and on investigational drug candidates in research & development. Pre-established and free search functions allow to identify molecules according to their
Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D Drug Pipeline Database is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies, proteins and peptides on the market are provided.
An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.
Special Focus of the Database:
Prerequisite: Internet access.
Purchase of the subscription provides a 1-year online access to the data of the R&D Drug Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Sample Screenshots of R&D Drug Pipeline Database
as of November 12, 2014.